Medicare Enrolled
Dr. Ovidiu Negrea, M.D.
Hematology & Oncology · Savannah, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Negrea from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Negrea?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Negrea
Dr. Ovidiu Negrea is a hematology & oncology specialist in Savannah, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Negrea performed 121,602 Medicare services across 4,489 unique beneficiaries.
Between the years covered by Open Payments, Dr. Negrea received a total of $2,953 from 17 pharmaceutical and/or device companies across 35 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Negrea is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in GA
$2,953 industry payments
Medicare Practice Summary
Medicare Utilization ↗121,602
Medicare services
Top 6% in GA for hematology & oncology
4,489
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,080 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nivolumab injection (Opdivo) | 21,680 | $24 | $88 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
20,910 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 15,860 | $1 | $6 |
| Pembrolizumab injection (Keytruda) | 14,200 | $42 | $157 |
| Paclitaxel chemotherapy injection | 10,790 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 4,800 | $19 | $64 |
| Iron infusion (Monoferric) | 4,200 | $16 | $74 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,590 | $6 | $25 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,364 | $0 | $1 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
3,215 | $5 | $135 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,820 | $1 | $41 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,433 | $8 | $29 |
| Injection, atropine sulfate, 0.01 mg | 2,400 | $0 | $1 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,298 | $59 | $277 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 880 | $3 | $42 |
| Injection, irinotecan, 20 mg | 783 | $2 | $35 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
729 | $90 | $390 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
688 | $90 | $421 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
637 | $8 | $9 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
558 | $11 | $66 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
476 | $2 | $39 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
472 | $10 | $67 |
| Anti-nausea injection (ondansetron/Zofran) | 416 | $0 | $3 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
394 | $60 | $214 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
360 | $93 | $654 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
326 | $20 | $103 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
323 | $2 | $7 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
287 | $44 | $205 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
285 | $73 | $210 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
267 | $7 | $126 |
| New patient office visit, complex (60-74 min) | 183 | $153 | $673 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
171 | $49 | $234 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
165 | $43 | $180 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
162 | $19 | $164 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
153 | $44 | $208 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
153 | $1 | $6 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
148 | $1 | $4 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
144 | $88 | $308 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
121 | $17 | $83 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
104 | $23 | $135 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
93 | $130 | $550 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
71 | $38 | $177 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
64 | $130 | $595 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
63 | $1 | $22 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
60 | $38 | $117 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
56 | $64 | $313 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
55 | $4 | $12 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
38 | $14 | $63 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
26 | $24 | $121 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
25 | $2 | $9 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
24 | $3 | $11 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $111 | $509 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
18 | $127 | $543 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
17 | $23 | $105 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $99 | $406 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
12 | $1 | $17 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
21.9% high complexity
72.5% medium
5.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,953
Total received (2018-2024)
Avg $422/year across 7 years
Bottom 46% in GA for hematology & oncology
17
Companies
35
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,101 (37.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$825 (27.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$728 (24.6%)
Other
Charitable contributions, space rental, and other categories
$299 (10.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$351
2023
$541
2022
$1,822
2021
$25
2020
$14
2019
$40
2018
$161
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$299
Tempus AI, Inc
$33
Adaptive Biotechnologies Corporation
$18
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Veracyte, Inc.
$994
Janssen Biotech, Inc.
$742
Novartis Pharmaceuticals Corporation
$315
AstraZeneca Pharmaceuticals LP
$242
Kite Pharma, Inc.
$214
Seagen Inc.
$123
Seattle Genetics, Inc.
$61
GENZYME CORPORATION
$57
Adaptive Biotechnologies Corporation
$39
Tempus AI, Inc
$33
Gilead Sciences, Inc.
$28
Bayer HealthCare Pharmaceuticals Inc.
$25
PFIZER INC.
$22
GE HealthCare
$18
ImmunoGen, Inc.
$15
Myriad Genetic Laboratories, Inc.
$13
TESARO, Inc.
$12
Top 3 companies account for 69.4% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · BAVENCIO · Elahere · IMBRUVICA · KISQALI · LIBTAYO · RYBREVANT · SUTENT · Stivarga · TAGRISSO · TUKYSA · Trodelvy · Yescarta · ZEJULA · clonoSEQ · myChoice CDx
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (37%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Hematology & oncology specialists within 10 mi
13
Per 100K population
4.4
County median income
$69,575
Nearest hospital
SAVANNAH HEALTH SERVICES LLC DBA MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Negrea is a mixed practice specialist, with above-average Medicare volume (top 6% in GA), with mixed engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Negrea experienced with nivolumab injection (opdivo)?
Based on Medicare claims data, Dr. Negrea performed 21,680 nivolumab injection (opdivo) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Negrea receive payments from pharmaceutical companies?
Yes. Dr. Negrea received a total of $2,953 from 17 companies across 35 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Negrea's costs compare to other hematology & oncology specialists in Savannah?
Dr. Negrea's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Negrea) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Savannah
Browse hematology & oncology specialists in Savannah ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
Veracyte, Inc. Payments to Doctors
See all physicians who received payments from Veracyte, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology